Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Axonics Inc
(NQ:
AXNX
)
67.20
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
67.20
Bid (Size)
51.00 (1)
Ask (Size)
70.00 (2)
Prev. Close
67.20
Today's Range
67.20 - 67.20
52wk Range
47.94 - 69.68
Shares Outstanding
46,134,513
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Axonics Stockholders Approve Merger Agreement with Boston Scientific
March 22, 2024
From
Axonics, Inc.
Via
Business Wire
Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
March 14, 2024
From
Axonics, Inc.
Via
Business Wire
Performance
YTD
+12.54%
+12.54%
1 Month
-1.54%
-1.54%
3 Month
-1.70%
-1.70%
6 Month
+24.47%
+24.47%
1 Year
+17.11%
+17.11%
More News
Read More
Axonics Responds to ITC Action by Medtronic
February 29, 2024
From
Axonics, Inc.
Via
Business Wire
Beyond The Numbers: 7 Analysts Discuss Axonics Stock
February 29, 2024
Via
Benzinga
Analyst Scoreboard: 5 Ratings For Axonics
January 09, 2024
Via
Benzinga
Why Axonics Stock Soared Today
January 08, 2024
Via
The Motley Fool
Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results
February 28, 2024
From
Axonics, Inc.
Via
Business Wire
AXONICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Axonics, Inc. - AXNX
February 27, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
Why Medical Devices Giant Boston Scientific Shares Are Rising Today
January 31, 2024
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
January 16, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
Health Care Company Boston Scientific Announces Acquisition of Axonics
January 08, 2024
Via
Benzinga
Stock Market Rally Rebounds; Nvidia, Tesla, JPMorgan, Bitcoin ETFs In Focus: Weekly Review
January 12, 2024
Via
Investor's Business Daily
Topics
ETFs
Robinhood, Palo Alto Networks And 2 Other Stocks Insiders Are Selling
January 11, 2024
Via
Benzinga
10 Top Stocks With a Strong Buy Rating Right Now
January 09, 2024
Via
InvestorPlace
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
January 08, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
Why Is Crocs (CROX) Stock Up 20% Today?
January 08, 2024
Via
InvestorPlace
Why Is Axonics (AXNX) Stock Up 20% Today?
January 08, 2024
Via
InvestorPlace
Why Is Bladder Disorder Focused Axonics Stock Trading Higher Today?
January 08, 2024
Via
Benzinga
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 08, 2024
Via
Benzinga
J&J, Merck, Boston Scientific Debut Trio Of Splashy Takeovers Topping $3 Billion In Value
January 08, 2024
Via
Investor's Business Daily
AXNX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Axonics, Inc. Is Fair to Shareholders
January 08, 2024
From
Halper Sadeh LLC
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 08, 2024
Via
Benzinga
Axonics Announces Definitive Agreement to be Acquired by Boston Scientific
January 08, 2024
From
Axonics, Inc.
Via
Business Wire
Axonics Reports Preliminary 4Q23 and Fiscal Year 2023 Revenue
January 08, 2024
From
Axonics, Inc.
Via
Business Wire
Axonics to Present at the J.P. Morgan Healthcare Conference
December 27, 2023
From
Axonics, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.